News

Metabolic Health Declining Among the Obese, Despite Improvements in BP and Lipids

Author and Disclosure Information

 

FROM THE JOURNAL OF THE AMERICAN HEART ASSOCIATION

References

The study was supported by the Department of Veterans Affairs, the National Institutes of Health, and the University of Alabama Diabetes Research Center.

Dr. Guo had no financial disclosures. Dr. Garvey disclosed relationships with multiple pharmaceutical companies.

Pages

Recommended Reading

Persistent Cough, Peculiar Heart Sound
Clinician Reviews
The Cruise With No Snooze
Clinician Reviews
Sweet Spot Found for LDL-C Reduction to Minimize Risk
Clinician Reviews
Insomnia in Young Men Boosts Cardiovascular and Cerebrovascular Risk
Clinician Reviews
FDA Panel Narrowly Endorses Empagliflozin’s Cardiovascular Mortality Benefit
Clinician Reviews
Menopause and Cardiovascular Risk Examined in Type 1 Diabetes
Clinician Reviews
As Preventive, H2RA Poses Risks for Patients on Clopidogrel After Bleeding Ulcer
Clinician Reviews
Long-acting Opioids Increase Cardiovascular Deaths in Noncancer Patients
Clinician Reviews
Simplify Cardiac Risk Assessment for Rheumatologic Conditions
Clinician Reviews
Statement Warns of Drugs Causing or Exacerbating Heart Failure
Clinician Reviews